New attention is being drawn to reduced physical activity among people taking GLP-1 receptor agonist medications, which are widely prescribed for weight management and diabetes. While these drugs can effectively lower body weight, experts suggest that decreased movement may have broader health implications beyond what the scale shows. The issue highlights the importance of maintaining fitness and activity levels during weight-loss treatment to support overall cardiovascular and metabolic health.
Weight & Metabolism · Jun 15, 2026 · 1 hour ago
Physical Activity Decline on GLP-1 Medications Raises Health Concerns
Read the full story at mindbodygreen.com →
This summary was prepared by the HealthyFreePress editorial desk; the underlying reporting belongs to the linked publisher. Nothing here is medical advice — see our Medical Disclaimer and Editorial Policy.